[Alendronate for the prevention and treatment of postmenopausal osteoporosis. A survey of a Cochrane review].
Eiken
Pia A
PA
Kardiologisk-endokrinologisk Afdeling, Hillerød Hospital, DK-3400 Hillerød. piei@hil.regionh.dk
Abrahamsen
Bo
B
D019386:Alendronate / Q000627:therapeutic use*; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D019317:Evidence-Based Medicine; D005260:Female; D005598:Fractures, Spontaneous / Q000517:prevention & control; D006801:Humans; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy* / Q000517:prevention & control; D011322:Primary Prevention; D055502:Secondary Prevention
D050071:Bone Density Conservation Agents; D019386:Alendronate